In this episode of The Lead recorded at HRS2026, host Danesh Kella, MBBS, FHRS is joined by Jeffrey S. Healey, MD, FHRS and Fred M. Kusumoto, MD, FHRS to discuss the journal article, Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation (The CLOSURE-AF Trial). Together, they review the study findings comparing left atrial appendage closure with medical therapy in patients with atrial fibrillation and discuss the potential implications for clinical practice.

Learning Objectives

  • Review the design and key findings of the CLOSURE-AF Trial comparing left atrial appendage closure with medical therapy in patients with atrial fibrillation.
  • Discuss the comparative considerations of left atrial appendage closure and medical therapy for the management of atrial fibrillation.
  • Examine the potential clinical implications of the CLOSURE-AF Trial for treatment decision-making in patients with atrial fibrillation.

 

Host: Danesh Kella, MBBS, FHRS

Guests: Jeffrey S. Healey, MD, FHRS and Fred M. Kusumoto, MD, FHRS

 

Disclosures:

D. Kella

  • Honoraria/Speaking/Consulting Fee: Zoll Medical Corporation, MBW Spectrum

 

J. Healey

  • Honoraria/Speaking/Consulting Fee: Boston Scientific, Servier
  • Research: Pfizer, Boston Scientific, Medtronic, Inc.
  • Speakers' Bureau: Bristol-Myers Squibb

 

F. Kusumoto

  • No relevant disclosures

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The Lead Podcast presented by Heart Rhythm Society. Innehållet i podden är skapat av The Lead Podcast presented by Heart Rhythm Society och inte av, eller tillsammans med, Poddtoppen.